A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction

Maillard, Luc; Raynaud, P; Hamon, Martial; Monassier, Jean‐Pierre; Khalife, Khalifé; Steg, Philippe Gabriel; Serruys, Patrick W.; Beygui, Farzin; Guermonprez, J L; Spaulding, Christian; Boulenc, Jean-Marc; Lipiecki, Janusz; Lafont, Antoine; Brunel, Philippe; Grollier, Gilles; Köning, René; Coste, Pierre; Favereau, Xavier; Lancelin, B; Belle, Éric Van

doi:10.1016/s0735-1097(00)00612-4

Cited by 137 publications

(79 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Abciximab was used in a small proportion of patients in other studies. 69,73 PTCA: participant characteristics Thirty-nine studies included patients with both stable and unstable angina; one study 38 was limited to patients with stable angina. Eleven studies included patients within 12-24 hours of MI onset.…”

Section: Adjunctive Treatmentmentioning

confidence: 99%

“…Eleven studies included patients within 12-24 hours of MI onset. Of these, four 60,61,68,69 excluded patients with cardiogenic shock.…”

Section: Adjunctive Treatmentmentioning

confidence: 99%

“…In 29 studies, clinical follow-up was available at 6 months; however, few studies reported on the longer term outcomes for each intervention arm. Thirteen studies 38,39,42,43,49,53,54,56,57,63,65,69,77 reported outcomes at 1 year, two studies 61,67 at 2 years, one study 52 at 4 years and in one study the longest period of follow-up was 5 years. 38 Three studies 45,68,86 reported on follow-up separately for those with diabetes mellitus (DM).…”

Section: Follow-upmentioning

confidence: 99%

“…However, the comparison of DES and BMS for single-vessel disease does not involve any question of mortality and therefore can easily be represented in a much simpler way. [52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69]70+ CIC In this section we introduce a simplified model for this purpose, which can be presented on a single Excel worksheet and encapsulates virtually all the detail of the original LRIG model for comparison of stents.…”

Section: Economic Modelling: Simplified Model For Non-drug Eluting Vementioning

confidence: 99%

See 3 more Smart Citations

Coronary artery stents: a rapid systematic review and economic evaluation

Hill¹,

Bagust²,

Bakhai³

et al. 2004

Health Technol Assess

144

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA programme commissions research only on topics where it has identified key gaps in the evidence needed by the NHS. Suggestions for topics are actively sought from people working in the NHS, the public...

show abstract

Section: Adjunctive Treatmentmentioning

confidence: 99%

“…Eleven studies included patients within 12-24 hours of MI onset. Of these, four 60,61,68,69 excluded patients with cardiogenic shock.…”

Section: Adjunctive Treatmentmentioning

confidence: 99%

Section: Follow-upmentioning

confidence: 99%

Section: Economic Modelling: Simplified Model For Non-drug Eluting Vementioning

confidence: 99%

See 2 more Smart Citations

Coronary artery stents: a rapid systematic review and economic evaluation

Hill¹,

Bagust²,

Bakhai³

et al. 2004

Health Technol Assess

144

View full text Add to dashboard Cite

show abstract

“…rate during the chronic stage of myocardial infarction, 1,[3][4][5][6][7] improvements in cardiac function, as evaluated by indices such as the left ventricular end-diastolic dimension (LVDd) and the LV ejection fraction (LVEF), a decreased mortality rate, and a shortened period of hospitalization. [8][9][10] These findings appear to result from the significantly larger mean minimal luminal diameter (MLD) obtained after coronary arterial stenting than that obtained with POBA alone, and favorable (thrombolysis in myocardial infarction; TIMI grade 3) coronary arterial blood flow during reperfusion therapy.…”

mentioning

confidence: 99%

<b>Does Coronary Artery Stenting for Acute Myocardial Infarction Improve Left Ventricular Overloading at the Chronic Stage?</b>

et al. 2004

View full text Add to dashboard Cite

SUMMARYIn the present study, we evaluated whether stenting is useful for cardiac overloading, using ANP, BNP, and 99m Tc-tetrofosmin myocardial scintigraphy. It has been reported that coronary artery stenting is useful for cardiac functions for acute myocardial infarction (AMI). The subjects were 110 patients with AMI successfully treated by direct angioplasty. These patients were subgrouped into two groups: the S group (underwent stenting; 54 patients) and the P group (underwent POBA alone; 56 patients). Extent scores reflecting decreased myocardial blood flow were calculated at myocardial areas showing a radioactivity count of less than -2 × standard deviations compared to the database of normal subjects.The ratio of extent scores to defect scores (extent/defect ratio) was compared between the P and S groups. Both ANP and BNP levels in the S group were lower than in the P group at the chronic stage (1 and 3 months after reperfusion therapy). Moreover, the end-diastolic volume index from the left ventriculography 3 months after reperfusion therapy was significantly larger in the P than the S group. The extent/defect ratio was significantly lower in the P group (2.8 ± 0.2) than the S group (3.5 ± 0.3), suggestive of a microcirculation disorder. These results suggest that cardiac overloading and left ventricular remodeling are decreased more by stenting than by POBA alone, probably because stenting prevents decreased myocardial blood flow around the infarct myocardium. (Jpn Heart J 2004; 45: 217-229)

show abstract

Development of high-performance stent: Gelatinous photogel-coated stent that permits drug delivery and gene transfer

Nakayama

Kim

Nishi

et al. 2001

J. Biomed. Mater. Res.

View full text Add to dashboard Cite

Hydrogel-coated metallic stents may provide supplementary functions such as local drug delivery and gene transfer in addition to mechanical dilation function. To this end, we used a photoreactive material consisting of gelatin macromer (multiple styrene-derivatized gelatin) and carboxylated camphorquinone (photo-initiator). A few minutes of visible light irradiation of a stent after dip-coating of an aqueous solution of the photoreactive material resulted in the formation of a homogeneously crosslinked gelatinous layer on the entire exterior surface of the stent. As the metal stent, gold stents under development were used. Rhodamine-conjugated albumin as a model drug or adenoviral vector expressing bacterial beta-galactosidase (AdLacZ) as a model gene were photo-immobilized in the gelatinous gel layer. In vitro experiments using hybrid tubular tissue, which is a self-shrinkaged, vascular smooth muscle cell-incorporated type-I collagen gel, as a vascular model, showed that the immobilized dye-derivatized albumin was released on and permeated into tissues, as observed by confocal laser microscopy, and that the cells transfected with immobilized AdLacZ produced beta-galactosidase up to almost 3 weeks, as observed by x-gal staining. In preliminary in vivo experiments these drug- or adenovirus-immobilized stents were implanted in rabbit common carotid arteries. Within 3 weeks of implantation, drug permeation and gene expression in the vascular tissues were observed, indicating that the gelatinous photogel effectively serves as a matrix or coating for a bioactive stent,which permits drug release as well as gene transfer. This intraluminal approach has the potential to realize drug and gene therapy in atherosclerotic plaque.

show abstract

A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction

Abstract: In the setting of primary angioplasty for AMI, as compared with a strategy of conventional balloon angioplasty, systematic stenting using the Wiktor stent results in lower rates of angiographic restenosis.

Cited by 137 publications

References 36 publications

Coronary artery stents: a rapid systematic review and economic evaluation

Coronary artery stents: a rapid systematic review and economic evaluation

<b>Does Coronary Artery Stenting for Acute Myocardial Infarction Improve Left Ventricular Overloading at the Chronic Stage?</b>

Development of high-performance stent: Gelatinous photogel-coated stent that permits drug delivery and gene transfer

Contact Info

Product

Resources

About